MA
ABMD

MUFG Americas’s Abiomed Inc ABMD Stock Holding History

MUFG Americas’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8
Closed -$3K – 846
2020
Q4 		$3K Buy
+8
New +$2.21K ﹤0.01% 690
2016
Q4 		– Sell
-127
Closed -$16K – 1188
2016
Q3 		$16K Hold
127
– – ﹤0.01% 767
2016
Q2 		$14K Buy
127
+77
+154% +$7.66K ﹤0.01% 779
2016
Q1 		$5K Buy
+50
New +$4.22K ﹤0.01% 962

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MUFG Americas's ABMD Position: Q1 2021 in Review

MUFG Americas sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 8 shares — an estimated $3K sold.

MUFG Americas first reported a position in ABMD in Q1 2016 and held it in 4 quarters. The position peaked at $16K in Q3 2016. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • MUFG Americas reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • MUFG Americas sold 8 Abiomed Inc shares in Q1 2021, an estimated $3K.
  • MUFG Americas first reported a position in Abiomed Inc in Q1 2016 and held it in 4 quarters.
  • MUFG Americas's Abiomed Inc position peaked at $16K in Q3 2016.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on MUFG Americas's 13F filing for Q1 2021, filed 30 Apr 2021.